By Michele Maatouk
Date: Wednesday 24 Dec 2025
(Sharecast News) - France's Sanofi said on Wednesday that it has agreed to buy US hepatitis vaccine maker Dynavax in a $2.2bn deal.
No recent information was found.
| Currency | Euro |
| Share Price | 82.29 |
| Closing Price Change | 1.10 |
| % Change | 0.00 % |
| 52 Week High | 109.62 |
| 52 Week Low | 77.52 |
| Volume | 0 |
| Shares Issued | 1,256.00m |
| Beta | 0.82 |
| Strong Buy | 13 |
| Buy | 7 |
| Neutral | 6 |
| Sell | 0 |
| Strong Sell | 1 |
| Total | 27 |

You are here: research